Pliant Therapeutics, Inc. (PLRX) has a consensus analyst rating of Buy, based on 16 analysts covering the stock. Of those, 8 recommend buying, 7 recommend holding, and 1 recommend selling.
The analyst consensus price target for PLRX is $3.00, representing a +130.8% upside from the current price of $1.3. Price targets range from a low of $3.00 to a high of $3.00.
